Joby and Archer Aviation Are Falling Just as Air Taxis Near Reality
Here's why Joby and Archer Aviation stocks are falling as the evtol dream nears the commercialization stage later this year.
Stocks · News reference
Cathie Wood Swaps Robinhood for SpaceX, Archer—Did ARK Pivot Back to Moonshot Innovation?
Cathie Wood sold $10M of Robinhood while adding $15M to SpaceX and boosting Archer Aviation. Here's what ARK Invest's ETF rotation signals.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Prediction: Here's What a $5,000 Investment in Joby Aviation Will Be Worth in 3 Years
Joby Aviation, an eVTOL aircraft developer, has underperformed since going public but could see significant growth once the FAA certifies its commercial flights. The company's S4 aircraft offers advantages over competitors like Archer Aviation, with backing from Toyota, Delta Air Lines, and Uber. Analysts project revenue could grow from $53M in 2025 to $435M by 2028, potentially doubling the company's market cap to $14B over three years, though the stock remains highly speculative with ongoing cash burn and shareholder dilution.
Why Archer Aviation's Management of Hawthorne Airport Matters Just as Much as Developing Its Own Aircraft
Archer Aviation's acquisition of Hawthorne Airport in California is a strategic move that provides both near-term testing facilities for its Midnight eVTOL aircraft and long-term benefits as a hub for air taxi services. The airport's central location could allow Archer to collect fees from competitors while establishing a recurring revenue stream, though the company's success ultimately depends on obtaining commercial approval for its Midnight aircraft.
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood's Ark Invest added to positions in Nvidia, Broadcom, and Intellia Therapeutics on Friday as these stocks declined. Nvidia exceeded earnings expectations with 106% revenue growth and raised guidance to 70% for fiscal 2028, now trading at 14x forward earnings. Broadcom is on track for accelerating growth with an upcoming earnings report. Intellia, a gene-editing biotech, has declined over 50% from recent highs but remains well-funded with analyst support.
Cathie Wood Trims 40K Shopify Shares After August Rally: Where ARK Is Reinvesting?
Cathie Wood's ARK sold 40,392 Shopify shares after a 25% August rally. Here's what ARKK and ARKW are betting on next.